Clinical trial
An Open, Multicenter, Randomized Phase III Clinical Study on Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
NCT02677597 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open, Multicenter, Randomized Phase III Clinical Study on Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Fudan University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- January 31, 2019
- Enrollment
- 268 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.